CordenPharma

European CDMO network specializing in peptide API manufacturing across multiple facilities. Frankfurt site offers early clinical peptide APIs and R&D. Muttenz site developing new GLP-1 plant as part of 900M EUR investment.

CordenPharma is listed as a CDMO in the peptide supply chain, serving Europe markets from Germany / Switzerland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.